Our Services
Eurofins CDMO provides phytocannabinoid development and manufacturing services via synthetic routes. Leveraging our robust track record in scalable active pharmaceutical ingredient (API) development and manufacturing, we specialize in producing pharmaceutical-grade, high-quality phytocannabinoids, particularly those challenging to extract from cannabis plants or seeds. Additionally, we provide reference standards for a wide variety of phytocannabinoids.
Phytocannabinoids via Synthetic Routes
We apply our rigorous API development expertise to produce well-characterized synthetic phytocannabinoids and reference standards of high purity, which is not readily achieved through traditional extraction involving cannabis plants or seeds.
Our capabilities:
- Synthetic routes & process development for phytocannabinoid molecules
- Manufacturing processes for highly pure phytocannabinoids
- Analytical development expertise for quality control
- Reference standards preparation
- cGMP compliant facility
- Project management
Drug Product (DP) services
Eurofins CDMO applies innovative formulation technologies for bioavailability enhancement and stability improvement of cannabinoids (CBD & THC), with patient compliant dosage forms (mini tablets, sublingual, buccal, gums) as ultimate goal. We have analytical expertise for related method development in-house and required controlled substances licenses available.
Our Capabilities:
- Pre-formulation, formulation development
- Analytical method development
- Stability assessment (Accelerated stability study, ASPA, ICH stability)
- GMP manufacturing
- QC testing & QP release
- Controlled Substances GMP storage
- Clinical trial supply
- Scale-up & facility transfers
- Regulatory dossier writing (IMPD – IND- CTD)
Get in touch with our experts